Cart
sales@molnova.com
Licogliflozin
CAS No. 1291094-73-9
Licogliflozin( LIK066 )
Catalog No. M11181 CAS No. 1291094-73-9
A novel sodium glucose transporter type 1 and type 2 (SGLT1/2) inhibitor for the oral treatment of type 2 diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 1008 | Get Quote |
|
| 100MG | 1674 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLicogliflozin
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel sodium glucose transporter type 1 and type 2 (SGLT1/2) inhibitor for the oral treatment of type 2 diabetes.
-
DescriptionA novel sodium glucose transporter type 1 and type 2 (SGLT1/2) inhibitor for the oral treatment of type 2 diabetes.Obesity Phase 2 Clinical.
-
In VitroLicogliflozin (LIK066) is a non-anti-fibrotic treatment agent for non-alcoholic steatohepatitis (NASH).
-
In Vivo——
-
SynonymsLIK066
-
PathwayGPCR/G Protein
-
TargetSGLT
-
RecptorSGLT
-
Research AreaMetabolic Disease
-
IndicationObesity
Chemical Information
-
CAS Number1291094-73-9
-
Formula Weight416.47
-
Molecular FormulaC23H28O7
-
Purity>98% (HPLC)
-
SolubilityH2O : 2 mg/mL4.80 mM
-
SMILESO[C@H]1[C@H](C2=CC=C(CC)C(CC3=CC=C4OCCOC4=C3)=C2)O[C@H](CO)[C@@H](O)[C@@H]1O
-
Chemical Name(1S)-1,5-anhydro-1-C-{3-[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]-4-ethylphenyl}-D-glucitol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Canagliflozin
A highly potent and selective SGLT2 inhibitor with IC50 of 4.4, 3.7 and 2.0 nM for hSGLT2, rSGLT2 and mSGLT2, respectively.
-
KGA-2727
KGA-2727 is a potent and selective SGLT1 inhibitor, with Kis of 97.4 nM and 43.5 nM for human and rat SGLT1, respectively.?The selectivity ratios (Ki for SGLT2/Ki for SGLT1) of KGA-2727 are 140 (human) and 390 (rat).?KGA-2727 for the treatment of diabete.KGA-2727, which has a pyrazole-O-glucoside structure, as the first selective SGLT1 inhibitor.?
-
Ipragliflozin
A highly potent and selective SGLT2 inhibitor with IC50 of 14 nM for hSGLT2.
